# Prediabetes Progression and Screening: Catch the Window > FPG, A1C, and OGTT define the prediabetes band. Progression to T2D is common—and often preventable. *Published 2026-07-10 · Updated 2026-07-10 · By Marcus Chen* In short Prediabetes = ADA bands (FPG 100–125, A1C 5.7–6.4, OGTT 140–199). Screen early; **lifestyle (DPP ~58%)** and selective metformin change progression. Experimental adjuncts never replace this pathway. Prediabetes is a warning light with a still-open door. The failure mode is silence until neuropathy or heart disease arrives. *This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.* ## How the three tests complement each other A1C reflects ~2–3 months of glycemia but can mislead with hemoglobinopathies or anemia. FPG captures hepatic/fasting physiology. OGTT stresses the system and catches isolated IGT. Discordance is common—repeat and contextualize. ## What raises pretest probability Central adiposity, sedentary life, family history, certain ancestries, PCOS, sleep apnea, and prior gestational diabetes. Medications such as some antipsychotics and glucocorticoids can worsen glycemia. Men and women share mechanisms but differ in fat patterning and hormonal modifiers. Key reference points TestPrediabetes bandDiabetes band (ADA) FPG100–125 mg/dL≥126 mg/dL 2-h OGTT140–199 mg/dL≥200 mg/dL A1C5.7–6.4%≥6.5% PreventionLifestyle firstDPP benchmark Drug exampleMetformin selectiveClinician-guided ## What prevention looks like operationally ~5–7% weight loss targets, ≥150 minutes/week activity patterns as in prevention programs, dietary quality, sleep, and tobacco avoidance. CDC-recognized DPP lifestyle programs operationalize counseling. Medications when criteria and preference align. ## Monitoring cadence If prediabetic, recheck labs on clinician schedules (often at least annually, sooner if rising). Escalate education when numbers trend up. Celebrate stable improvement with the same seriousness as disease treatment. Screen for blood pressure and lipids—the risk cluster travels together. Sources: [ADA diagnosis cut points](https://diabetes.org/about-diabetes/diagnosis); [DPP NEJM 2002](https://www.nejm.org/doi/full/10.1056/NEJMoa012512); [ADA Standards of Care professional hub](https://professional.diabetes.org/standards-of-care). Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. ## Sources 1. [ADA diagnosis cut points](https://diabetes.org/about-diabetes/diagnosis) 2. [DPP NEJM 2002](https://www.nejm.org/doi/full/10.1056/NEJMoa012512) 3. [ADA Standards of Care professional hub](https://professional.diabetes.org/standards-of-care) --- Source: https://healthcanon.com/metabolic-health/prediabetes-progression-screening-guide Index: https://healthcanon.com/llms.txt · Full text: https://healthcanon.com/llms-full.txt